Cutter & Co Brokerage’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,944
| Closed | -$210K | – | 267 |
|
|
2021
Q4 | $210K | Sell |
4,944
-1,700
| -26% | -$72.2K | 0.06% | 243 |
|
|
2021
Q3 | $294K | Sell |
6,644
-799
| -11% | -$35.4K | 0.07% | 215 |
|
|
2021
Q2 | $423K | Sell |
7,443
-245
| -3% | -$13.9K | 0.1% | 175 |
|
|
2021
Q1 | $575K | Sell |
7,688
-2,429
| -24% | -$182K | 0.14% | 137 |
|
|
2020
Q4 | $875K | Sell |
10,117
-723
| -7% | -$62.5K | 0.23% | 94 |
|
|
2020
Q3 | $663K | Buy |
10,840
+593
| +6% | +$36.3K | 0.2% | 102 |
|
|
2020
Q2 | $426K | Buy |
10,247
+2,290
| +29% | +$95.2K | 0.14% | 130 |
|
|
2020
Q1 | $229K | Buy |
7,957
+668
| +9% | +$19.2K | 0.09% | 172 |
|
|
2019
Q4 | $526K | Buy |
7,289
+945
| +15% | +$68.2K | 0.18% | 112 |
|
|
2019
Q3 | $890K | Hold |
6,344
| – | – | 0.29% | 90 |
|
|
2019
Q2 | $1.16M | Buy |
6,344
+130
| +2% | +$23.8K | 0.37% | 72 |
|
|
2019
Q1 | $988K | Buy |
6,214
+455
| +8% | +$72.3K | 0.28% | 78 |
|
|
2018
Q4 | $552K | Buy |
5,759
+949
| +20% | +$91K | 0.21% | 111 |
|
|
2018
Q3 | $679K | Sell |
4,810
-500
| -9% | -$70.6K | 0.23% | 108 |
|
|
2018
Q2 | $831K | Hold |
5,310
| – | – | 0.32% | 87 |
|
|
2018
Q1 | $855K | Buy |
5,310
+120
| +2% | +$19.3K | 0.34% | 78 |
|
|
2017
Q4 | $855K | Sell |
5,190
-36
| -0.7% | -$5.93K | 0.35% | 71 |
|
|
2017
Q3 | $326K | Sell |
5,226
-70
| -1% | -$4.37K | 0.13% | 162 |
|
|
2017
Q2 | $422K | Buy |
5,296
+1,196
| +29% | +$95.3K | 0.17% | 136 |
|
|
2017
Q1 | $291K | Buy |
+4,100
| New | +$291K | 0.12% | 174 |
|